Your browser is no longer supported. Please, upgrade your browser.
BioSig Technologies, Inc.
Index- P/E- EPS (ttm)-1.90 Insider Own8.20% Shs Outstand30.93M Perf Week3.74%
Market Cap109.02M Forward P/E- EPS next Y-0.28 Insider Trans-2.95% Shs Float23.25M Perf Month-17.78%
Income-52.20M PEG- EPS next Q-0.15 Inst Own17.20% Short Float12.13% Perf Quarter-39.67%
Sales- P/S- EPS this Y-13.70% Inst Trans-0.30% Short Ratio11.39 Perf Half Y-7.50%
Book/sh0.79 P/B4.22 EPS next Y51.70% ROA-169.90% Target Price- Perf Year-70.53%
Cash/sh0.86 P/C3.85 EPS next 5Y- ROE-206.10% 52W Range2.79 - 12.19 Perf YTD-14.62%
Dividend- P/FCF- EPS past 5Y-1.50% ROI- 52W High-72.68% Beta1.74
Dividend %- Quick Ratio5.60 Sales past 5Y- Gross Margin- 52W Low19.35% ATR0.29
Employees49 Current Ratio5.70 Sales Q/Q- Oper. Margin- RSI (14)43.04 Volatility8.77% 8.68%
OptionableYes Debt/Eq0.00 EPS Q/Q49.60% Profit Margin- Rel Volume1.01 Prev Close3.19
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume247.50K Price3.33
Recom2.00 SMA20-3.51% SMA50-17.73% SMA200-33.98% Volume249,457 Change4.39%
Mar-30-20Initiated ROTH Capital Buy $9
May-04-21 06:28PM  
May-03-21 12:00PM  
Apr-27-21 09:30AM  
Apr-15-21 11:45AM  
Apr-14-21 09:29AM  
Apr-13-21 09:32AM  
Apr-09-21 09:32AM  
Apr-08-21 09:32AM  
Apr-06-21 09:45AM  
Apr-05-21 10:00AM  
Mar-30-21 08:30AM  
Mar-29-21 09:15AM  
Mar-19-21 12:15PM  
Mar-10-21 05:30PM  
Mar-09-21 04:45PM  
Mar-05-21 09:44AM  
Mar-04-21 09:15AM  
Feb-16-21 08:45AM  
Feb-11-21 08:30AM  
Feb-10-21 10:00AM  
Feb-08-21 08:35AM  
Feb-02-21 08:00AM  
Jan-28-21 08:35AM  
Jan-27-21 04:30PM  
Jan-15-21 09:32AM  
Jan-14-21 09:32AM  
Jan-13-21 01:35PM  
Jan-12-21 09:32AM  
Jan-11-21 12:13AM  
Jan-06-21 10:00AM  
Dec-18-20 08:30AM  
Dec-16-20 09:45AM  
Dec-11-20 07:51AM  
Dec-10-20 03:00PM  
Dec-03-20 11:00AM  
Dec-02-20 11:41AM  
Nov-30-20 11:00AM  
Nov-19-20 11:32AM  
Nov-12-20 02:11PM  
Oct-29-20 02:05PM  
Oct-28-20 10:00AM  
Oct-26-20 11:04AM  
Sep-30-20 09:27AM  
Sep-22-20 10:55AM  
Sep-21-20 11:01AM  
Sep-15-20 10:00AM  
Sep-14-20 03:00PM  
Sep-09-20 12:15PM  
Sep-02-20 10:15AM  
Aug-31-20 05:00PM  
Aug-25-20 10:45AM  
Aug-17-20 12:16PM  
Aug-06-20 10:00AM  
Aug-05-20 02:09PM  
Aug-04-20 09:25AM  
Aug-03-20 02:00PM  
Jul-30-20 01:00PM  
Jul-23-20 08:30AM  
Jul-20-20 01:50PM  
Jul-17-20 02:42PM  
Jul-16-20 05:30PM  
Jul-13-20 01:42PM  
Jul-10-20 01:15PM  
Jul-01-20 09:15AM  
Jun-29-20 08:18AM  
Jun-24-20 09:20AM  
Jun-22-20 02:30PM  
Jun-17-20 07:55AM  
Jun-08-20 03:02PM  
Jun-05-20 09:10AM  
Jun-04-20 09:25AM  
Jun-03-20 11:45AM  
Jun-01-20 10:42AM  
May-28-20 08:40AM  
May-20-20 10:12AM  
May-18-20 08:32AM  
May-14-20 08:15AM  
May-07-20 03:17PM  
May-05-20 02:10PM  
May-01-20 10:39AM  
Apr-30-20 09:20AM  
Apr-24-20 02:30PM  
Apr-23-20 09:15AM  
Apr-21-20 02:36PM  
Apr-17-20 02:07PM  
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ODONNELL JEFFREY FDirectorFeb 08Sale5.1242,762219,100151,629Feb 09 09:15 PM
ODONNELL JEFFREY FDirectorFeb 05Sale5.0062,238311,271194,391Feb 09 09:15 PM
CHAUSSY STEVEChief Financial OfficerDec 01Buy4.352,0008,699681,128Dec 02 09:00 AM
LONDONER KENNETH LChief Executive OfficerNov 30Buy4.652,0009,3001,345,558Dec 02 09:01 AM
LONDONER KENNETH LChief Executive OfficerNov 24Buy4.331,0004,3301,343,558Nov 25 09:45 AM
LONDONER KENNETH LChief Executive OfficerNov 23Buy4.413,00013,2301,342,558Nov 25 09:45 AM
LONDONER KENNETH LChief Executive OfficerNov 18Buy3.954,50017,7551,339,558Nov 19 09:45 AM
LONDONER KENNETH LChief Executive OfficerNov 17Buy3.894,00015,5451,335,058Nov 19 09:45 AM
LONDONER KENNETH LChief Executive OfficerNov 16Buy3.985,00019,9001,331,058Nov 17 09:46 AM
LONDONER KENNETH LChief Executive OfficerNov 13Buy3.902,0007,8001,326,058Nov 16 09:48 AM
LONDONER KENNETH LChief Executive OfficerNov 12Buy3.665,00018,3001,324,058Nov 13 09:45 AM
LONDONER KENNETH LChief Executive OfficerNov 10Buy3.457,20024,8071,319,058Nov 12 09:47 AM
LONDONER KENNETH LChief Executive OfficerNov 09Buy3.4216,60056,8161,311,858Nov 10 09:45 AM
LONDONER KENNETH LChief Executive OfficerNov 06Buy3.3412,50041,7651,295,258Nov 09 10:00 AM
LONDONER KENNETH LChief Executive OfficerMay 29Buy9.264,00037,0201,282,758May 29 11:30 AM
ZELDIS JEROME BDirectorMay 28Buy10.491,00010,489107,944May 28 10:58 AM
LONDONER KENNETH LChief Executive OfficerMay 26Buy10.843,60039,0141,278,758May 26 10:57 AM